Securities Suit Against Par Pharma Execs To Go On
A federal judge has ruled that a securities class action can continue against Par Pharmaceutical Cos. Inc.'s former chief executive officer and a former vice president, but has cleared one former...To view the full article, register now.
Already a subscriber? Click here to view full article